Sowell Financial Services LLC Edwards Lifesciences Corp Transaction History

Sowell Financial Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$83.84 - $104.76 $300,147 - $375,040	-3,580 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$78.68 - $90.67 $25,256 - $29,105	-321 Reduced 8.23%	3,580 $328,000
Q4 2020 Jan 13, 2021	SELL	$71.69 - $91.23 $7,025 - $8,940	-98 Reduced 2.45%	3,901 $356,000
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $63,696 - $82,893	948 Added 31.07%	3,999 $319,000
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $71,637 - $95,802	1,245 Added 68.94%	3,051 $211,000
Q1 2020 May 12, 2020	SELL	$52.41 - $81.0 $4,612 - $7,128	-88 Reduced 4.65%	1,806 $341,000
Q4 2019 Feb 07, 2020	BUY	$71.7 - $82.09 $87,832 - $100,560	1,225 Added 183.11%	1,894 $147,000
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $41,176 - $50,462	669 New	669 $147,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.